Charles Rodolphe Brupbacher Preis

Die Stiftung verleiht alle zwei Jahre den Charles Rodolphe Brupbacher Preis für Krebsforschung an Wissenschaftler, die auf dem Gebiet der Grundlagenforschung hervorragende Leistungen erbracht haben. Die Preisverleihung findet statt im Rahmen eines internationalen, wissenschaftlichen Symposiums, an dem auch der öffentliche Charles Rodolphe Brupbacher Vortrag gehalten wird.

Preisträger 2017

Prof. Sir Adrian Peter Bird
University of Edinburgh
Edinburgh, United Kingdom
DNA methylation patterns and cancer (pdf)

Prof. Dr. Laurence Zitvogel
Gustave Roussy Cancer Center
Paris, Frankreich
The role of immunogenic cell death and the gut microbiota in cancer treatment (pdf)

Prof. Dr. Guido Kroemer
Université Paris Descartes
Paris, Frankreich
Cancer cell stress and death - cell-autonomous and immunological considerations (pdf)

Von links: Michael O. Hengartner (Rektor der UZH), Sir Adrian Bird, Laurence Zitvogel, Guido Kroemer, Georg C. Umbricht (Präsident der Stiftung)

Preisträger 2015

Prof. Dr. Irving L. Weissman
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
Stanford, California, USA
The view from stem cell land: Stem cell biology in regeneration and cancer (pdf)

Prof. Dr. Joan Massagué
Sloan Kettering Institute
Memorial Sloan Kettering Cancer Center
New York, USA
Molecular Basis of Metastasis (pdf)

Oben (von links): Dr. Klaus W. Grätz (Dekan der Medizinischen Fakultät), Dr. Irving L. Weissman, Georg C. Umbricht (Stiftungsrat) Unten (von links): Dr. Klaus W. Grätz, Dr. Joan Massagué, Georg C. Umbricht

Preisträger 2013

Prof. Dr. Michael Karin
Department of Pharmacology
University of San Diego
La Jolla, California, USA
Inflammation and Cancer: Effects, Mechanisms and Therapeutic Implications (pdf) 

Von links: Georg C. Umbricht (Stiftungsrat), Dr. Michael Karin, Klaus W. Grätz (Dekan der Medizinischen Fakultät)

Preisträger 2011

Prof. Dr. Bert Vogelstein
Howard Hughes Medical Institute
The Johns Hopkins University
Baltimore, Maryland, USA
The genetic basis of human cancer and its implications for patient management (pdf)

Prof. Dr. Jan H. Hoeijmakers
Department of Genetics Erasmus Medical Center
Erasmus University
Rotterdam, The Netherlands  
DNA damage and its impact on cancer, aging and longevity (pdf)

Von links: Klaus W. Grätz (Dekan der Medizinischen Fakultät), Prof. Dr. Bert Vogelstein, Mme Frédérique Brupbacher (Stifterin), Prof. Dr. Jan H. Hoeijmakers, Prof. Dr. Andreas Fischer

Preisträger 2009

Dr. Nubia Muñoz
International Agency for Research on Cancer (IARC) emerit. Wissenschaftlerin
Lyon, France  
From causality to prevention: The case of cervial cancer (pdf)

Prof. Sir Richard Peto
Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU)
University of Oxford
Oxford, United Kingdom  
The absolute benefits of anti-cancer drugs and of tobacco control (pdf)

Von links: Prof. Sir Richard Peto, Dr. Nubia Muñoz

Preisträger 2007

Prof. Dr. Lloyd J. Old
Ludwig Institute for Cancer Research
New York, USA  
Contributions to the Field of Cancer Immunology (pdf)

Prof. Dr. Robert D. Schreiber
Department of Pathology and Immunology
Washington University,
School of Medicine
St. Louis, Missouri, USA  
Cancer Immunoediting: Deciphering the Complex Interaction Between Immunity and Developing Tumors (pdf)

Prof. Dr. Mark J. Smyth
Cancer Immunology Program
Peter MacCallum Cancer Centre
East Melbourne, Victoria, Australia
Extrinsic tumor suppression by innate and adaptive immunity (pdf)

Von links: Prof. Dr. Mark J. Smyth, Mme Frédérique Brupbacher (Stifterin), Prof. Dr. Robert D. Schreiber, Prof. Dr. Lloyd J. Old, Dr. Hans Erhart Brunner (Wissenschaftlicher Beirat)

Preisträger 1993-2005

Prof. Dr. Mariano Barbacid
Centro Nacional de Investigaciones Oncologicas
Madrid, Spain   

The Molecular Bases of Human Cancer: a 25 Year Journey

Prof. Dr. Klaus Rajewsky
The CBR Institute for Biomedical Research
Harvard Medical School
Boston, MA, USA    The Janus Face of Antibody Formation:
Protective Function and Tumor Risk
Prof. Dr. Rudolf Jaenisch
Whitehead Institute for Biomedical Research, MIT
Cambridge, MA, USA   

Nuclear Cloning and the Reversibility of Cancer

Prof. Dr. Erwin Wagner
Institute of Molecular Pathology
Vienna, Austria   

Unravelling the Functions of AP-1 (Fos/Jun) in Mouse Development and Disease
Prof. Dr. Brian Druker
Oregon Health Sciences University
Portland, Oregon, USA   

Clinical and Basic Oncology: New Developments
Prof. Dr. George Klein
Microbiology and Tumor Biology Center (MTC)
Karolinska Institute
Stockholm, Sweden   

Cancer and the New Biology

Prof. Dr. Harald zur Hausen
Deutsches Krebsforschungzentrum
Heidelberg, Germany   

Cancer Causation by Viruses

Prof. Dr. Laurent Degos
Institut Universitaire d'Hématologie
Hôpital Saint Louis
Paris, France   

Differentiation Therapy of Cancer

Prof. Dr. Zhen-yi Wang
Shanghai Institute of Hematology
Rui-Jin Hospital
Shanghai Second Medical University
Shanghai, PR China   

Treatment of Acute Promyelocytic Leukemia with All-Trans Retinoic Acid: A Model of Differential Therapy in Cancer
Prof. Dr. Alfred G. Knudson
Fox Chase Cancer Center
Philadelphia, PA, USA   

Hereditary Cancer

Prof. Dr. Robert A. Weinberg
Whitehead Institute for Biomedical Research, Rui-Jin Hospital
Department of Biology, MIT
Cambridge, MA, USA   

Genes and Cancer
Prof. Dr. Arnold J. Levine
Department of Molecular Biology
Lewis Thomas Laboratory
Princeton University
Princeton, N.J., USA   

Functions of the p53 Gene and Protein

Prof. Dr. David P. Lane
Cancer Research Campaign Laboratories
Department of Biochemistry
University of Dundee
Dundee, Scotland   

The p53 Pathway, Past and Future